President Donald Trump announces an expansion of TrumpRx.gov, the administration’s direct-to-consumer prescription drug discount platform. Multiple outlets report that TrumpRx is adding more than 160 prescription medications, bringing the total number of available drugs to over 800. The announcement is described as the second expansion of the program in a short period, with Trump saying the added drugs are offered at discounted prices. One outlet also reports that Trump claims the program has saved Americans more than $400 million, presenting the figure as an estimate of cumulative savings associated with the platform. Another outlet characterizes the platform as federal government-run and focuses on the scale of the update, noting the new total of over 800 discounted medications. Across the reports, the central points are the number of drugs being added, the resulting total, and the discounted pricing purpose of the TrumpRx initiative. The coverage does not provide detailed information in the excerpts about specific drug names, eligibility rules, or enforcement or oversight mechanisms.